Fatal heparin-induced thrombocytopenia (HIT) during warfarin thromboprophylaxis following orthopedic surgery: Another example of 'spontaneous'HIT?

Journal of Thrombosis and Haemostasis

Volumn 6, Issue 9, 2008, Pages 1598-1600

  Jay, R M ^a   Warkentin, Ted E ^b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c HAMILTON REGIONAL LABORATORY MEDICINE PROGRAM   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; WARFARIN;

ADULT; ANTICOAGULATION; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; ENZYME IMMUNOASSAY; FEMALE; HEART ARREST; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; INTENSIVE CARE UNIT; ORTHOPEDIC SURGERY; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROPHYLAXIS; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOSIS; TOTAL KNEE REPLACEMENT;

AGED; FATAL OUTCOME; FEMALE; HEPARIN; HUMANS; ORTHOPEDIC PROCEDURES; THROMBOCYTOPENIA; WARFARIN;

EID: 49849098449     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2008.03040.x     Document Type: Article

References (10)

1. Warkentin TE, Kelton JG. Delayed-onset heparin-induced thrombocytopenia and thrombosis. Ann Intern Med 2001; 135: 502-6.
2. Rauova L, Zhai L, Kowalska MA, Arepally GM, Cines DB, Poncz M. Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: Diagnostic and therapeutic implications. Blood 2006; 107: 2346-53.
3. Kelton JG, Sheridan D, Santos A, Smith J, Steeves K, Smith C, Brown C, Murphy WG. Heparin-induced thrombocytopenia: Laboratory studies. Blood 1988; 72: 925-30.
4. Warkentin TE, Sheppard JI, Sigouin CS, Kohlmann T, Eichler P, Greinacher A. Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia. Blood 2006; 108: 2937-41.
5. Matsuo T, Suzuki S, Matsuo M, Kobayashi H. Preexisting antibodies to platelet factor.4-heparin complexes in patients with acute coronary syndrome who have no history of heparin exposure. Pathophysiol Haemost Thromb 2005; 34: 18-22.
6. Martin-Toutain I, Piette JC, Diemert MC, Faucher C, Jobic L, Ankri A. High prevalence of antibodies to platelet factor.4 heparin in patients with antiphospholipid antibodies in absence of heparin-induced thrombocytopenia. Lupus 2007; 16: 79-83.
7. Alpert D, Mandl LA, Erkan D, Yin W, Peerschke EI, Salmon JE. Anti-heparin platelet factor.4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome. Ann Rheum Dis 2008; 67: 395-401.
8. Warkentin TE, Makris M, Jay RM, Kelton JG. A spontaneous prothrombotic disorder resembling heparin-induced thrombocytopenia. Am J Med 2008; 121: 632-6.
9. Warkentin TE. Clinical picture of heparin-induced thrombocytopenia. In: Warkentin TE, Greinacher A, eds. Heparin-Induced Thrombocytopenia, 4th edn. New York: Informa Healthcare USA, Inc., 2007: 21-66.
10. Warkentin TE, Maurer BT, Aster RH. Heparin-induced thrombocytopenia associated with fondaparinux. N Engl J Med 2007; 356: 2653-4.